studi
attempt
defin
differ
hemagglutininesteras
glycoprotein
bovin
coronavirus
bcv
recent
past
isol
neonat
calf
diarrhoea
ncd
winter
dysenteri
wd
syndrom
basi
strain
differenti
relat
clinic
sourc
isol
five
wdassoci
bcv
isol
studi
could
distinguish
past
ncdisol
hemagglutin
ha
properti
c
receptordestroy
enzym
rde
activ
rat
erythrocyt
lack
reactiv
ncd
isol
four
ha
inhibit
hai
monoclon
antibodi
mab
direct
glycoprotein
refer
wdassoci
quebec
strain
although
minor
differ
could
demonstr
compar
biolog
properti
wdisol
recent
ncdisol
past
ncd
isol
lack
reactiv
wd
hai
mab
wherea
recent
ncd
isol
display
two
distinct
reactiv
pattern
attempt
defin
sequenc
differ
gene
wd
ncd
strain
reveal
high
nucleotid
nt
ident
scatter
amino
acid
differ
seemingli
unrel
clinic
origin
isol
hai
mab
reactiv
bovin
coronaviru
bcv
import
enteropathogen
agent
bovin
speci
replic
matur
enterocyt
small
intestin
colon
caus
sever
diarrhoea
neonat
calv
ncd
chronic
shed
adult
cattl
ad
viru
report
also
respons
acut
enter
infect
adult
cattl
winter
season
diseas
usual
refer
winter
dysenteri
wd
character
acut
onset
dark
liquid
hemorrhag
diarrhoea
accompani
decreas
milk
product
variabl
depress
anorexia
adult
cattl
field
isol
infect
upper
respiratori
tract
feedlot
cattl
lead
lesion
interstiti
pneumon
bcv
well
character
hemagglutin
coronaviru
viral
particl
mostli
spheric
envelop
nm
diamet
display
doubl
fring
surfac
project
viral
genom
compris
helicoid
nucleocapsid
consist
larg
singlestrand
rna
molecul
posit
polar
approxim
kb
length
encod
three
major
structur
protein
coronavirion
phosphoryl
nucleocapsid
protein
n
kda
integr
matrix
glycoprotein
kda
spike
glycoprotein
kda
form
long
clubshap
surfac
project
member
hemagglutin
coronavirus
includ
hemagglutin
encephalomyel
viru
swine
hev
human
respiratori
coronaviru
murin
hepat
coronavirus
mhv
turkey
enter
coronaviru
tcv
bcv
particl
also
possess
addit
kda
envelopeassoci
glycoprotein
hemagglutininesteras
made
two
separ
kda
subunit
link
togeth
disulfid
bond
glycoprotein
associ
hemagglutin
receptor
destroy
enzym
rde
activ
present
one
serotyp
identifi
amongst
bcv
isol
despit
involv
differ
clinic
diseas
data
obtain
recent
serolog
studi
use
polyclon
well
anti
antih
monoclon
antibodi
suggest
exist
differ
subgroup
bcv
contain
strain
either
ncd
wd
ad
genom
level
minor
variat
gene
demonstr
virul
avirul
vaccin
strain
bcv
recent
gene
one
repres
quebec
wdassoci
strain
sequenc
compar
attenu
mebu
strain
two
highli
enteropahogen
ncd
strain
isol
period
although
sequenc
homolog
demonstr
mebu
strain
distinct
aa
substitut
identifi
within
signal
peptid
near
sequenc
put
esteras
domain
glycoprotein
wd
strain
character
mab
glycoprotein
strain
defin
two
distinct
subgroup
among
bcv
isol
associ
either
typic
outbreak
wd
ncd
quebec
dairi
herd
variabl
also
demonstr
amongst
ncd
strain
use
anti
mab
present
studi
attempt
defin
biolog
serolog
genom
differ
recent
past
bcv
isol
ncd
wd
syndrom
basi
strain
differenti
relat
clinic
sourc
isol
cell
cultureadapt
attenu
mebu
strain
vaccin
strain
bcv
obtain
american
type
cultur
collect
atcc
vr
rockvil
md
prototyp
ncd
strain
origin
isol
diarrhea
fluid
twoweekold
calf
attenu
follow
success
passag
fetal
bovin
kidney
fbk
cell
bcvque
strain
anoth
attenu
ncd
strain
isol
diarrheic
calv
quebec
canada
propag
least
passag
vero
follow
passag
mdbk
cell
prior
sequenc
studi
present
studi
refer
mebu
strain
quebec
refer
strain
well
repres
field
isol
bcv
associ
either
ncd
wd
outbreak
obtain
nonvaccin
dairi
herd
five
geograph
area
southern
quebec
propag
success
passag
human
rectal
tumor
cell
presenc
uml
bovin
pancreat
trypsin
previous
describ
previou
experiment
infect
studi
demonstr
wd
ncd
field
bcv
strain
inocul
oral
oneto
twoweekold
calv
passag
mdbk
cell
still
highli
virul
infect
titer
cell
cultureadapt
bcv
strain
determin
titrat
clarifi
tissu
cultur
medium
use
endpoint
dilut
procedur
calculaion
tcid
sml
previous
describ
hemagglutin
activ
clarifi
infect
cultur
supernat
ha
hai
test
rat
erythrocyt
also
perform
previous
describ
extracellular
virion
variou
bcv
isol
purifi
ml
clarifi
infect
cell
cultur
fluid
isopycn
ultracentrifug
sucros
gradient
determin
acetyl
esteras
ae
activ
variou
bcv
isol
aliquot
l
purifi
prepar
adjust
contain
approxim
amount
viral
particl
determin
neg
stain
electron
microscopi
ad
ml
pb
contain
mmpnitrophenyl
acet
pnpa
hydrolysi
substrat
follow
incub
min
monitor
wavelength
nm
spectromet
spectron
milton
roy
receptor
destroy
enzym
rde
activ
determin
accord
storz
et
al
express
ratio
ha
titer
determin
incub
h
c
ha
titer
determin
shift
c
h
lead
activ
enzym
activ
elut
viral
particl
surfac
erythrocyt
four
antih
mab
obtain
follow
fusion
experi
splenocyt
balbc
mice
immun
enrich
peplomer
fraction
wdassoci
strain
specif
andor
kda
correspond
monomer
dimer
form
glycoprotein
mab
previous
determin
western
blot
immunoprecipit
reactiv
observ
toward
kda
glycoprotein
mab
either
subisotyp
infect
titer
variou
field
bcv
isol
rang
tcid
sml
success
passag
ha
titer
c
vari
tabl
gener
wd
isol
display
higher
ae
activ
ncd
isol
except
ncd
isol
five
wd
isol
test
rde
activ
titer
vari
passag
cell
howev
case
wd
strain
higher
rde
activ
titer
detemin
lower
cell
cultur
passag
first
two
passag
thu
report
rang
tabl
ncdassoci
bcv
isol
includ
mebu
strain
except
rde
titer
appear
possess
minim
rde
activ
sinc
reduct
ha
titr
notic
shift
incub
c
data
crossreact
mab
direct
wdassoci
strain
bcv
isol
analys
also
depict
tabl
mab
major
differ
could
demonstr
hai
reactiv
pattern
wdassoci
bcv
isol
obtain
ncdassoci
isol
inde
four
antih
mab
display
similar
hai
antibodi
titer
obtain
homolog
strain
four
wdassoci
isol
test
except
mab
fail
react
isol
howev
none
antih
mab
show
reactiv
toward
refer
mebu
strain
also
case
recent
ncd
isol
distinct
pattern
hai
mab
reactiv
observ
ncd
isol
collect
inde
ncd
isol
behav
like
older
ncd
isol
wherea
reactiv
profil
ident
wd
isol
prepar
genom
rna
aliquot
l
purifi
viru
infect
celllys
supplement
l
rnaguard
pharmacia
rna
extract
perform
onestep
guanidinium
isothiocyanateacid
phenol
method
code
region
amplifi
rtpcr
alreadi
describ
use
follow
primer
oligo
heb
antisens
primer
repres
sequenc
posit
protein
gene
oligo
hea
sens
primer
correspond
sequenc
nt
upstream
end
gene
follow
purif
use
geneclean
ii
nucleic
acid
purif
kit
bio
lajolla
ca
rtpcr
amplifi
product
overhang
ligat
ta
clone
vector
pcrii
vector
invitrogen
co
san
diego
ca
provid
singl
overhang
insert
site
sequenc
cdna
clone
perform
strand
dideoxynucleotid
chaintermin
method
use
dna
polymeras
pharmacia
biotech
inc
autom
laser
fluoresc
dna
sequenc
pharmacia
lkb
sequenc
addit
primer
use
sequenc
gene
oligo
oligo
oligo
four
correspond
revers
complementari
primer
assess
error
rate
revers
transcriptas
taq
polymeras
clone
differ
rtpcr
event
sequenc
error
gener
polymeras
avoid
sequenc
randomli
select
clone
direct
subsequ
nt
deduc
aa
sequenc
comput
analys
aid
mac
vector
intern
biotechnolog
genework
intelligenet
inc
mountain
view
ca
program
gene
four
addit
quebec
wdassoci
bcv
field
isol
four
antigen
distinct
ncdassoci
bcv
field
isol
clone
sequenc
nucleotid
sequenc
access
number
emblgenbank
ddbj
assign
gene
quebec
enteropathogen
bcv
isol
comparison
studi
made
sequenc
gene
virul
attenu
refer
mebu
strain
genbank
access
number
highli
virul
ncd
strain
access
number
isol
earli
bcvque
strain
associ
acut
outbreak
ncd
quebec
dairi
farm
addit
previous
sequenc
quebec
wdassoci
strain
isol
access
number
quebec
ncdassoci
strain
access
number
access
number
isol
respect
case
gene
nt
long
encod
predict
protein
aa
residu
data
shown
frameshift
delet
insert
nonsens
mutat
observ
nucleotid
substitut
affect
posit
nt
sequenc
among
bcv
isol
studi
involv
purin
substitut
ct
tc
occur
mainli
woobl
base
thu
lead
silent
aa
mutat
tabl
gene
sequenc
four
addit
wdisol
contain
approxim
nt
substitut
comparison
refer
strain
compar
number
nt
substitut
identifi
case
four
antigenicallydistinct
ncd
strain
analys
compar
mebu
strain
percentag
nt
ident
bcv
isol
associ
enter
syndrom
vari
four
addit
wdassoci
bcv
isol
possess
nt
ident
refer
strain
highli
virul
strain
wdassoci
isol
show
two
nt
substitut
show
three
nt
substitut
compar
gene
recent
ncdassoci
isol
display
similar
reactiv
profil
four
antih
mab
data
comparison
deduc
aa
sequenc
eight
bcv
field
isol
studi
previous
sequenc
quebec
strain
isol
bcvque
wdassoci
strain
ncdassoci
refer
strain
mebu
summar
tabl
total
aa
substitut
identifi
amongst
field
isol
analys
comparison
deduc
protein
mebu
strain
remain
highli
conserv
follow
attenu
numer
passag
cell
cultur
strain
analysi
predict
aa
sequenc
bcv
isol
studi
also
reveal
put
nlink
glycosyl
site
nxst
previous
identifi
ncdassoci
mebu
strain
wdassoci
strain
locat
aa
posit
conserv
bcv
field
isol
associ
enter
aa
locat
glycoprotein
given
accord
zhang
et
al
syndrom
well
put
esteras
activ
domain
fgd
aa
posit
howev
similarli
previous
describ
highli
virul
ncdstrain
wdstrain
four
addit
quebec
wdassoci
isol
well
ncdassoci
isol
contain
prolin
substitut
aa
posit
predict
signal
peptid
case
ncdassoci
isol
studi
previous
postul
substitut
may
alter
matur
intracellular
transport
glycoprotein
still
remain
elucid
also
appear
wdassoci
bcv
isol
possess
prolin
substitut
observ
virul
strain
aa
posit
also
case
quebec
ncdassoci
field
isol
collect
analysi
reveal
high
nt
ident
scatter
aa
differ
seemingli
unrel
clinic
origin
isol
hai
mab
reactiv
previous
report
refer
quebec
wdassoci
strain
data
obtain
present
studi
show
four
addit
wdassoci
field
isol
analys
differ
prototyp
bcv
mebu
strain
respect
clinic
symptom
ha
pattern
c
c
higher
rde
activ
rat
erythrocyt
howev
similar
ha
rde
properti
observ
two
recent
ncdassoci
isol
studi
mean
characterist
uniqu
wdassoci
isol
least
bcv
isol
associ
attenu
mebu
vaccin
strain
bcvque
strain
distinguish
capac
hemagglutin
c
lower
rde
activ
test
rat
erythrocyt
molecular
level
two
uniqu
pro
substitut
previous
identifi
refer
wdstrain
one
signal
peptid
aa
posit
one
near
put
esteras
domain
fgd
aa
posit
interestingli
fgd
sequenc
found
well
preserv
bcv
isol
studi
also
previous
demonstr
other
compar
virul
avirul
bcv
strain
mhvjhm
influenza
c
virus
data
obtain
thu
indic
esteras
activ
site
essenti
structur
function
glycoprotein
howev
previous
hypothes
domain
probabl
determin
bcv
virul
sinc
conserv
virul
avirul
strain
well
strain
associ
variou
clinic
symptom
whether
pro
substitut
aa
posit
involv
viral
infect
previous
suggest
still
demonstr
interestingli
substitut
present
protein
wdassoci
bcv
isol
test
ncdassoci
isol
show
higher
ae
activ
although
exist
bcv
strain
distinguish
clinic
syndrom
exist
distinct
bcv
serotyp
yet
elucid
previou
investig
detect
minor
strain
variat
amongst
cell
cultureadapt
bcv
strain
isol
ncd
case
europ
enter
respiratori
case
unit
state
iif
hai
test
recent
anti
mab
found
distinguish
vaccin
avirul
wildtyp
virul
bcv
strain
mildli
denatur
western
immunoblot
neutral
assay
also
previous
report
antigen
plural
amongst
bcv
isol
ncd
case
quebec
partial
reaction
indirect
elisa
mab
glycoprotein
present
studi
four
antih
mab
inhibit
ha
activ
homolog
strain
react
refer
mebu
strain
display
strong
hai
titer
wd
isol
test
disagr
previou
find
reactiv
mab
restrict
wd
strain
similar
hai
titer
obtain
one
recent
ncdisol
test
although
data
demonstr
variat
affect
antigen
determin
glycoprotein
occur
among
bcv
strain
isol
quebec
within
last
ten
year
divers
appear
unrel
clinic
symptom
agreement
recent
find
tsunemitsu
saif
case
bcv
strain
isol
unit
state
although
seem
alter
antigen
determin
glycoprotein
quebec
isol
sequenc
analys
show
mani
distinct
variat
common
field
isol
would
distinguish
specif
epitop
target
mab
one
may
postul
mab
studi
direct
toward
conform
depend
rather
linear
epitop
conform
chang
protein
lack
epitop
could
also
explain
serolog
data
obtain
previou
studi
demonstr
two
antih
mab
test
mab
fail
react
western
blot
toward
protein
homolog
strain
suggest
mab
probabl
direct
toward
conform
depend
epitop
howev
conform
chang
protein
could
result
aa
variat
substitut
pro
residu
certain
region
could
entail
alter
threedimension
structur
protein
thu
serv
either
expos
mask
certain
epitop
present
strain
other
similar
conclus
may
drawn
higher
rde
activ
variou
strain
chang
conform
protein
could
result
enhanc
enzymat
activ
promin
expos
region
sequenc
analysi
strain
isol
prior
need
support
statement
previou
studi
hai
also
serolog
test
hat
allow
differenti
bcv
strain
associ
enter
syndrom
sinc
nt
substitut
could
reveal
gene
wd
ncd
bcv
strain
serolog
differenti
may
rather
involv
glycoprotein
also
associ
ha
activ
retrospect
studi
humor
immun
respons
individu
express
recombin
glycoprotein
requir
determin
two
major
envelopeassoci
glycoprotein
mainli
involv
antigen
variabl
recent
older
ncdand
wdassoci
quebec
bcv
field
isol
